Nuchev Limited (ASX:NUC) shares have continued their recent momentum with a 28% gain in the last month alone. The last 30 days bring the annual gain to a very sharp 48%.
After such a large jump in price, when almost half of the companies in Australia's Food industry have price-to-sales ratios (or "P/S") below 0.7x, you may consider Nuchev as a stock probably not worth researching with its 2.1x P/S ratio. Although, it's not wise to just take the P/S at face value as there may be an explanation why it's as high as it is.
Our free stock report includes 5 warning signs investors should be aware of before investing in Nuchev. Read for free now.Check out our latest analysis for Nuchev
What Does Nuchev's Recent Performance Look Like?
There hasn't been much to differentiate Nuchev's and the industry's revenue growth lately. Perhaps the market is expecting future revenue performance to improve, justifying the currently elevated P/S. You'd really hope so, otherwise you're paying a pretty hefty price for no particular reason.
If you'd like to see what analysts are forecasting going forward, you should check out our free report on Nuchev.What Are Revenue Growth Metrics Telling Us About The High P/S?
Nuchev's P/S ratio would be typical for a company that's expected to deliver solid growth, and importantly, perform better than the industry.
Retrospectively, the last year delivered an exceptional 43% gain to the company's top line. Pleasingly, revenue has also lifted 48% in aggregate from three years ago, thanks to the last 12 months of growth. Therefore, it's fair to say the revenue growth recently has been superb for the company.
Turning to the outlook, the next year should generate growth of 53% as estimated by the sole analyst watching the company. With the industry only predicted to deliver 9.0%, the company is positioned for a stronger revenue result.
In light of this, it's understandable that Nuchev's P/S sits above the majority of other companies. Apparently shareholders aren't keen to offload something that is potentially eyeing a more prosperous future.
What We Can Learn From Nuchev's P/S?
Nuchev shares have taken a big step in a northerly direction, but its P/S is elevated as a result. Generally, our preference is to limit the use of the price-to-sales ratio to establishing what the market thinks about the overall health of a company.
We've established that Nuchev maintains its high P/S on the strength of its forecasted revenue growth being higher than the the rest of the Food industry, as expected. Right now shareholders are comfortable with the P/S as they are quite confident future revenues aren't under threat. Unless the analysts have really missed the mark, these strong revenue forecasts should keep the share price buoyant.
We don't want to rain on the parade too much, but we did also find 5 warning signs for Nuchev (3 can't be ignored!) that you need to be mindful of.
If you're unsure about the strength of Nuchev's business, why not explore our interactive list of stocks with solid business fundamentals for some other companies you may have missed.
If you're looking to trade Nuchev, open an account with the lowest-cost platform trusted by professionals, Interactive Brokers.
With clients in over 200 countries and territories, and access to 160 markets, IBKR lets you trade stocks, options, futures, forex, bonds and funds from a single integrated account.
Enjoy no hidden fees, no account minimums, and FX conversion rates as low as 0.03%, far better than what most brokers offer.
Sponsored ContentValuation is complex, but we're here to simplify it.
Discover if Nuchev might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About ASX:NUC
Nuchev
A health and nutrition solutions company, produces, markets, and sells goat milk based formula and nutritional products under the Oli6 brand in Australia and China.
Excellent balance sheet moderate.
Similar Companies
Market Insights
Community Narratives
